By Wayne Cole SYDNEY (Reuters) -Asia shares slipped on Tuesday while the euro nursed its losses as investors pondered the downside of the U.S.-EU trade deal and the reality that punishing tariffs were here to stay,

But as recently as Wednesday, Mr. Trump floated a higher range, between 15% and 50%. Mr. Trump, who in April said the U.S. had 200 trade deals with other nations, has since said there are too many countries for individual trade deals with all of them and the U.S. will have "simple" tariffs for "most" countries.

A federal appeals court will soon hear oral arguments in a major case challenging Trump's "reciprocal" tariffs.

President Trump reached an agreement to impose 15% tariffs on the European Union, with a few exceptions for key industries like aircrafts, semiconductor equipment and certain chemicals. Bloomberg News Anchor and Correspondent David Gura joins Ana Cabrera to break down the implications the new tariff rate could have on Americans.

India's equity benchmarks inched lower on Tuesday amid caution over a delay in an interim trade deal with the United States, sustained foreign outflows and weak earnings.

Top trade officials from China and the United States have launched a new round of talks aimed at easing tensions over tariffs.

German auto companies embraced greater clarity but warned that even the lower rate of tariffs agreed between Brussels and Washington would still hurt.

Businesses both small and large are already reckoning with Trump's tariffs, and new levies are set to start this week.

Companies reporting today include Enterprise Products Partners ( EPD) and Waste Management ( WM ). See the full earnings calendar on Seeking Alpha, as well as today's economic calendar.

The American dollar has hit its rock bottom, at least since the Nixon days. The dollar is experiencing its worst value since 1973, and other factors may bring it even lower. There are a few tactics, however,

South Korean pharmaceutical firm Celltrion said on Tuesday that in an attempt to offset the risk of U.S. tariffs it had become the preferred bidder to acquire a U.S. manufacturing factory from an unnamed global pharmaceutical company.